key: cord-0853349-9xipsfna
authors: Song, Fengge; Shen, Yuanyuan; Wei, Yangdao; Yang, Chunrong; Ge, Xiaolin; Wang, Aimin; Li, Chaoyang; Wan, Yi; Li, Jinghong
title: Botulinum toxin as an ultrasensitive reporter for bacterial and SARS-CoV-2 nucleic acid diagnostics
date: 2021-03-15
journal: Biosens Bioelectron
DOI: 10.1016/j.bios.2020.112953
sha: 448c81cee8273e3711407d4ba62c0aaf6c7fe1b7
doc_id: 853349
cord_uid: 9xipsfna

The rapid identification of pathogenic microorganisms plays a crucial role in the timely diagnosis and treatment strategies during a global pandemic, especially in resource-limited area. Herein, we present a sensitive biosensor strategy depended on botulinum neurotoxin type A light chain (BoNT/A LC) activated complex assay (BACA). BoNT/A LC, the surrogate of BoNT/A which embodying the most potent biological poisons, could serve as an ultrasensitive signal reporter with high signal-to-noise ratio to avoid common strong background response, poor stability and low intensity of current biosensor methods. A nanoparticle hybridization system, involving specific binding probes that recognize pathogenic 16S rRNAs or SARS-CoV-2 gene site, was developed to measure double-stranded biotinylated target DNA containing a single-stranded overhang using Fluorescence Resonance Energy Transfer (FRET)-based assay and colorimetric method. The method is validated widely by six different bacteria strains and severe acute respiratory related coronavirus 2 (SARS-CoV-2) nucleic acid, demonstrating a single cell or 1 aM nucleic acid detecting sensitivity. This detection strategy offers a solution for general applications and has a great prospect to be a simple instrument-free colorimetric tool, especially when facing public health emergency.

All bacteria were purchased from the China Center of Industrial Culture Collection (CICC) and were cultured in trypticase soy broth until a centrifugation (6,000 r.p.m., 10 min) at 4 ℃. Lysozyme (15 mg/mL) /TE buffer and ∼200 mg of zirconia beads were added to the pellets followed by a thorough vortex. The harvested bacteria pellets were broken in a tissue cell-destroyer (NewZongKe Viral Disease Control Bio-Tech LTD.) with a small tube adapter for 9 runs of 30 s, with 15 s intervals. Subsequently, BRK Lysis buffer (Bacterial RNA kit, Omega) was added to the lysis mixture according to the protocol. And the RNA was extracted by HiBind® RNA Mini Columns with the final RNA yield detected on NanoDrop Microvolume Spectrophotometers (Thermo Scientific) and agarose gel electrophoresis (DYY-6D, Beijing Liuyi Biotechnology Co. Ltd).

For clinical blood samples provided friendly from the 187th hospital of Haikou, 2 mL of sample was centrifuged to harvest pellets. ACK Lysis Buffer (Gibco) was added and then followed by centrifugations to remove the red blood cells. The RNA was extracted as described above.

The pTIG-Trx-RBS-BoNT-ALC plasmid was constructed based on plasmid pTIG-Trx-BoNT-ALC provided from NovoPro Bioscience Inc (Yu et al., 2011) . First, Trx-RBS gene was amplified from pTIG-Trx-BoNT-ALC using primers: F-5' ATTCCATATGAGCGATAAAATTATTCACCTGA3', R-5' GGAATTCCTCCTTACCGGATCCCGCGGCCAGGTTAGCGTCGA3'. Amplicon was cloned into pMD19-T vector to form pMD19-T-Trx-RBS and sequenced by Sangon Biotech. The pMD19-T-Trx-RBS plasmid was digested with EcoR I and Nde I to excise the Trx-RBS DNA fragment, which was then subcloned into pTIG-Trx-BoNT-ALC plasmid. The engineered plasmid was digested by the same enzymes to produce a recombinant plasmid pTIG-Trx-RBS-BoNT-ALC. The correct pTIG-Trx-RBS-BoNT-ALC plasmid was transformed into E. coli strain BL21 (DE3) cells (TransGen Biotech) and the cells were cultured in Luria Bertani (LB) containing 100 g/mL ampicillin to express the engineered GBP-tagged BoNT/ALC protein.

The recombinant plasmids pET-22b(+)-Trx-SNAP25 and pTIG-Trx-BoNT-ALC were provided from NovoPro Bioscience Inc. and subsequently confirmed by DNA sequencing (Sangon Biotech). The SNAP25 protein was expressed in E. coli with plasmid pET-22b(+)-Trx-SNAP25 directly by using thioredoxin fusion expression system. And the GBP-tagged BoNT/A LC protein was co-expressed with thioredoxin in free form by inserting ribosome binding site (RBS) site in pTIG-Trx-BoNT-ALC between BoNT-ALC gene and thioredoxin gene (trxA) gene to yield a new expression vector, pTIG-Trx-RBS-BoNT-ALC. Plasmids (pET-22b(+)-Trx-SNAP25 and pTIG-Trx-RBS-BoNT-ALC) were transformed into trans BL21(DE3) pLysS chemically competent cell (TransGen Biotech, China) and were grown in Luria broth for growth at 37°C and 180 rpm until an OD600 of 0.6. At this time, the SNAP25 and BoNT/A LC protein expressions were induced by addition of IPTG at a final concentration of 0.5 mM with cells cooled down to 25 ℃ and 16 ℃ respectively for 16 h with shaking at 180 rpm. Bacterial cells were subsequently centrifuged at 8000 rpm for 10 min at 4°C, and pellets were harvested and resuspended in lysis buffer (20 mM Na3PO4, 500 mM NaCl, 40 mM imidazole, pH 7.4) followed by sonication. Clear supernatants were obtained by lysate centrifugation for 30 min at 4°C at 10,000 rpm following by filtration with 0.22 µm filters and added onto Bio-Scale Mini Nuvia IMAC Ni-Charged (Bio-Rad Laboratories, Inc., USA) for affinity chromatography purification according to the manufacturer's instruction (NGC Chromatography System, Bio-Rad Laboratories). Fractions containing SNAP25 were collected and stored at -80°C for later usage. While fractions containing BoNT/A LC were pooled and dialyzed at 4°C against storage buffer (50 mM HEPES, 200 mM NaCl, pH 7.4). Both SNAP25 and GBP-tagged BoNT/A LC were confirmed by SDS-PAGE and western blot (Bio-Rad Laboratories, Inc., USA).

The activity of engineered BoNT/A LC was detected by SNAPtide FRET assay and confirmed by S2 SDS-PAGE with the expressed SNAP25 protein as its cleavage substrate at the same time. BCA protein assay kit (Solarbio Life Sciences) was used to evaluate concentrations of the two proteins. To detect its activity, BoNT/A LC was diluted to different concentrations and added 5 μM SNAPtide substrate in cleavage buffer 1 (50 mM HEPES, pH 7.4, 0.05% TWEEN20) to measure the generating fluorescence in a fluorescence plate reader. Moreover, the BoNT/A LC of different concentrations were added 5 μM SNAP25 protein substrates with SDS-PAGE loading buffer mixed to terminate the cleavage reactions before being analyzed by coomassie blue stained acrylamide gel.

For the binding capability, 200 µL of anti-TAG sequence conjugated GNP at 10 nM and 200 µL of purified GBP-tagged BoNT/A LC (0.3 µM) were incubated at 37 ℃ for 0.5 h. The resultant mixture was centrifuged for 10 min at 10000 rpm. And the forming BNP pellets were washed and resuspended by 400 µL of cleavage buffer. Then 10 µL of the SNAPtide fluorescence detection assay was carried out in cleavage buffer, consisting of 5 μM SNAPtide and 5.6 µL of the BNPs. Meanwhile, a dilution series of the purified BoNT/A LC were added to the cleavage buffer in the same way as described above to prepare the standard curve. Finally, the BC% of BoNT/A LC on BNPs was estimated according to the prepared standard curve. Table S1 . Sequences of primers and probes for bacterial and viral detection. Figure S1 . Construction of pTIG-Trx-RBS-BoNT-ALC plasmid. Schematic of pTIG-Trx-RBS-BoNT-ALC plasmid construction (a). Trx-RBS gene was amplified from pTIG-Trx-BoNT-ALC plasmid (b). Amplicon was cloned into pMD19-T vector, forming positive pMD19-T-Trx-RBS clones (2, 8, 10 and 14) (c). The pMD19-T-Trx-RBS plasmid (1) and pTIG-Trx-BoNT-ALC plasmid (3) were digested with EcoR I and Nde I (2 and 4) (d). Analysis (e) of E. coli transformant positive and correct clones (1, 2 and 4 to 16) for pTIG-Trx-RBS-BoNT-ALC. The activities of engineered BoNT/A LC were detected by SNAPtide FRET assay (f) and SDS-PAGE (g) with the expressed SNAP25 protein as cleavage substrate in cleavage buffer 1. Figure S3 . Optimization of BoNT/A LC activities through SDS-PAGE analyses. SNAP25 protein was used as cleavage substrate in this experiment. BoNT/A LC cleavage activity with different cleavage buffers (cleavage buffer 1: 50 mM HEPES, 0.05% TWEEN20, pH 7.4; cleavage buffer 2: 50 mM HEPES, 20 μM ZnCl2, 0.05% TWEEN20, pH 7.4; cleavage buffer 3: 10 mM Tris-HCl with 20 mM NaCl, pH 7.6) (a). BoNT/A LC cleavage activity with different dilution buffers (dilution buffer A: 10 mM PB buffer at pH 7.4; dilution buffer B: 50 mM HEPES, 0.05% TWEEN20, pH 7.4; dilution buffer C: 50 mM HEPES, 200 mM NaCl, pH 7.6) (b). BoNT/A LC cleavage activity with or without TMAO in cleavage buffer (c). Figure S4 . Bacterial RNA extraction (a) and 16S amplification of cDNA template by using 27F/1492R primers (b). Figure S5 . Amplification and capture of biotinylated TAG overhang targets. Schematic of biotinylated TAG overhang targets acquisition (a). Biotinylated TAG overhang targets amplified from a dilution series of S. pyogenes were captured by streptavidin magnetic beads (b). Figure S10 . Bacteria detection by colorimetric BACA biosensor. BoNT/A LC based detection for serial dilutions of P. aeruginosa DNA (a). The reproducibility of response in relative absorbance intensity through BACA colorimetric method after exposure to the same target DNA in tests (b). Absorbance response for differential detection of 6 bacteria types (e). (n=3 technical replicates, bars represent mean ±s.d. ΔAbs represents the absolute value of background subtracted absorbance. NT represents no template control) S14 9. Clinical sample analysis Figure S11 . Clinical species-specific target detection by BACA biosensor. (n=3 technical replicates, bars represent mean ±s.d.) S15 Figure S12 . Clinical blood sample total RNA extraction and 16S amplification using respective specific primers. S16 Figure S13 . Sensitivity analysis of colorimetric BACA experiment for SARS-CoV-2 N gene plasmid. (n=3 technical replicates, bars represent mean ±s.d. NT represents no template control) S17 11. Pseudovrius detections using BACA biosensor Figure S14. Pseudovrius detections using BACA biosensor. (n=3 technical replicates, bars represent mean ±s.d. NT represents no template control)

Co-expression of tetanus toxin fragment C in Escherichia coli with thioredoxin and its evaluation as an effective subunit vaccine candidate